Erythropoietin therapy in a case of neonatal anemia after exposure to natalizumab throughout pregnancy
Abstract Background Natalizumab is a monoclonal antibody approved for the treatment of patients with relapsing-remitting multiple sclerosis. According to the current clinical recommendations, its use during pregnancy should be carefully evaluated only in women with highly active disease who plan a p...
Saved in:
Main Authors: | , , , , , , , , |
---|---|
格式: | 圖書 |
出版: |
BMC,
2021-03-01T00:00:00Z.
|
主題: | |
在線閱讀: | Connect to this object online. |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
因特網
Connect to this object online.3rd Floor Main Library
索引號: |
A1234.567 |
---|---|
復印件 1 | 可用 |